Conmed (CNMD) Tops Q1 EPS by 7c, provides guidance
Tweet
Share
E-mailGet Alerts CNMD Hot Sheet
Price: $33.83 +3.27%
EPS Growth %: -3.5%
Financial Fact:
Cost of sales: 83.58M
Today's EPS Names:
CRMT, More
EPS Growth %: -3.5%
Financial Fact:
Cost of sales: 83.58M
Today's EPS Names:
CRMT, More
Join SI Premium – FREE
Conmed (NYSE: CNMD) reported Q1 EPS of $0.89, $0.07 better than the analyst estimate of $0.82. Revenue for the quarter came in at $317 million versus the consensus estimate of $310.59 million.
GUIDANCE:
Conmed sees FY2026 EPS of $4.30-$4.45, versus the consensus of $4.35.
For earnings history and earnings-related data on Conmed (CNMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- HSBC Downgrades Stellantis NV (STLA:IM) (STLA) to Reduce
- Morgan Stanley Downgrades Repsol SA (REP:SM) (REPYY) to Equalweight
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
